Sponsor Seminar@BioJapan

Program

BioJapan2025 Sponsor Seminar   (2025.10.08,wed :Annex Hall F206)


JP

AI and Quantum Computing Pioneer a Paradigm Shift in Biotechnology

AIST is conducting research and development of medical and healthcare technologies, bio-manufacturing technologies, and resource recycling technologies that utilize AI technologies and quantum computing in order to cope with an aging society and to realize a bioeconomy society. In this seminar, AIST will introduce the changes that AI technology and next-generation quantum computing technology can bring to these fields and the goals to be achieved, while also providing examples of actual research and development.

AI and Quantum Computing Pioneer a Paradigm Shift in Biotechnology
Coordinator:MITSUDA Nobutaka
Director, Research Planning Office,Department of Life Science and Biotechnology, AIST
14:30-14:50
Quantum Computing in the Agile Dynamic Era

In July 2023, Global Research and Development Center for Business by Quantum-AI technology (G-QuAT) was established at the National Institute of Advanced Industrial Science and Technology (AIST) based on our country's quantum strategy. G-QuAT has installed a computing environment and evaluation facilities, including a GPU-based supercomputer and multiple quantum computers, and has begun full-scale operations. In this presentation, I will discuss G-QuAT's mission, strategy, and initiatives in the context of domestic and international quantum technology trends, as well as its potential applications in biotechnology.

14:50-15:10
Transformation and Acceleration Strategy for a Biomanufacturing Process Research Center Enabled by AI and Quantum Computing-and Its Potential
TANIGUCHI Takeaki
Principal Research Manager, Biomanufacturing and Process Research Center, AIST 

15:10-15:30
Next-Generation Drug Discovery with Quantum Computing and AI
HAMADA Michiaki
Invited Researcher, Cellular and Molecular Biotechnology Research Institute, AIST  

In this talk, I will introduce our research on next-generation drug discovery that integrates quantum computing and AI. Focusing on RNA aptamer drug development, I will explain our approach to solving optimization problems of sequence and secondary structure information derived from SELEX data using quantum annealing and Ising machines. I will also present how we formulate these problems with QUBO, incorporating RNA secondary structures, and share optimization results based on real data. This work highlights new possibilities in drug discovery enabled by the synergy of quantum and AI technologies.